Genetic heterogeneity and cancer drug resistance
Top Cited Papers
- 30 April 2012
- journal article
- editorial
- Published by Elsevier BV in The Lancet Oncology
- Vol. 13 (4), e178-e185
- https://doi.org/10.1016/s1470-2045(11)70335-7
Abstract
No abstract availableThis publication has 81 references indexed in Scilit:
- Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer DevelopmentCell, 2011
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- Signatures of mutation and selection in the cancer genomeNature, 2010
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLCCancer Cell, 2010
- Complex landscapes of somatic rearrangement in human breast cancer genomesNature, 2009
- A comprehensive catalogue of somatic mutations from a human cancer genomeNature, 2009
- A small-cell lung cancer genome with complex signatures of tobacco exposureNature, 2009
- Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2EMBO Molecular Medicine, 2009
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005
- Genetic heterogeneity of single disseminated tumour cells in minimal residual cancerThe Lancet, 2002